Biomarkers /

DLG1

Back to Biomarkers List
Associated Diseases

Overview

Location [1]
3q29
Protein [2]
Disks large homolog 1
Synonyms [1]
hdlg, SAP-97, DLGH1, SAP97

DLG1 is altered in 0.01% of all cancers with invasive breast carcinoma, high grade ovarian serous adenocarcinoma, neuroendocrine carcinoma, NOS, and non-small cell lung carcinoma having the greatest prevalence of alterations [3].

DLG1 GENIE Cases - Top Diseases

The most common alterations in DLG1 are DLG1-BRAF Fusion (0.02%), DLG1-KMT2A Fusion (0.01%), and DLG1-PIK3CA Fusion (0.04%) [3].

DLG1 GENIE Cases - Top Alterations

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.